Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

MRNA Company Profile and Key Details

NASDAQ : MRNA

Moderna, Inc.

$24.72
-0.475-1.89%
At Close 4:00 PM
63.84
BESG ScoreESG Rating

Price Chart

Stock Price Today

Moderna, Inc. (MRNA) stock declined over -1.89%, trading at $24.72 on NASDAQ, down from the previous close of $25.19. The stock opened at $25.28, fluctuating between $24.43 and $25.28 in the recent session.

Stock Snapshot

25.19
Prev. Close
25.28
Open
9.54B
Market Cap
385.82M
Number of Shares
24.43
Day Low
25.28
Day High
-2.66
P/E Ratio
88.56%
Free Float in %
-9.28
EPS (TTM)
36.36
Book Value
-10.04
Cash Flow per Share
6.67M
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 17, 202525.2825.2824.4324.736.67M
Apr 16, 202525.8526.0724.8125.195.4M
Apr 15, 202526.8227.2125.5226.246.99M
Apr 14, 202526.9427.1026.2426.806.45M
Apr 11, 202524.6926.2424.2626.2010.96M
Apr 10, 202525.8225.9023.7024.5012.64M
Apr 09, 202524.0227.6823.6826.6713.06M
Apr 08, 202526.4026.8924.1524.648.93M
Apr 07, 202524.0526.5223.1525.6413.24M
Apr 04, 202525.2025.7723.7625.1116.03M
Apr 03, 202526.6627.2025.7025.7312.72M
Apr 02, 202526.7928.7826.2627.7211.68M
Apr 01, 202528.7028.8527.0727.1611.58M
Mar 31, 202528.8928.9526.8028.3520.42M
Mar 28, 202532.0432.5031.0231.125.67M
Mar 27, 202531.5432.5731.2532.126.2M
Mar 26, 202533.8534.0831.2931.487.97M
Mar 25, 202534.3134.8633.5133.856.94M
Mar 24, 202532.8034.8732.8034.1710.5M
Mar 21, 202532.0532.8031.5232.669.33M

Contact Details

Cambridge, MA 02139

United States

Website: https://www.modernatx.comContact: 617 714 6500

About Company

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Company Information

Employees5800
Beta2.23
Sales or Revenue$6.75B
5Y Sales Change%10.869%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Moderna, Inc. (MRNA) stock price?
Moderna, Inc. (NASDAQ: MRNA) stock price is $24.72 in the last trading session. During the trading session, MRNA stock reached the peak price of $25.28 while $24.43 was the lowest point it dropped to. The percentage change in MRNA stock occurred in the recent session was -1.89% while the dollar amount for the price change in MRNA stock was -$0.48.
MRNA's industry and sector of operation?
The NASDAQ listed MRNA is part of Biotechnology industry that operates in the broader Healthcare sector. Moderna, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of MRNA?
Mr. Stephane Bancel
Chief Executive Officer & Director
Mr. Juan Andres
Pres of Strategic Partnerships & Enterprise Expansion
Dr. Jerh Collins Ph.D.
Chief Technical Operations & Quality Officer
Dr. John V. W. Reynders Ph.D.
Chief Information Officer
Mr. James M. Mock
Chief Financial Officer
Ms. Lavina Talukdar CFA
Senior Vice President & Head of Investor Relations
Dr. Stephen Hoge M.D.
Pres
Mr. Brad Miller
Chief Information Officer
Dr. Melissa J. Moore Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
Ms. Arpa Garay
Chief Commercial Officer
Colleen Hussey
Senior Director of Corporation Communications
Ms. Shannon Thyme Klinger
Chief Legal Officer & Corporation Sec.
How MRNA did perform over past 52-week?
MRNA's closing price is 6.76% higher than its 52-week low of $23.15 where as its distance from 52-week high of $170.47 is -85.5%.
How many employees does MRNA have?
Number of MRNA employees currently stands at 5,800.
Link for MRNA official website?
Official Website of MRNA is: https://www.modernatx.com
How do I contact MRNA?
MRNA could be contacted at phone 617 714 6500 and can also be accessed through its website. MRNA operates from 200 Technology Square, Cambridge, MA 02139, United States.
How many shares of MRNA are traded daily?
MRNA stock volume for the day was 6.67M shares. The average number of MRNA shares traded daily for last 3 months was 11.34M.
What is the market cap of MRNA currently?
The market value of MRNA currently stands at $9.54B with its latest stock price at $24.72 and 385.82M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph